Abstract
Introduction
In the course of sepsis, altered endothelial function appears in macro-and microcirculation and contributes significantly to the development of multiple organ failure [1, 2] . Reconstitution of the endothelial layer can be initiated by the recruitment of vascular progenitor cells [3] [4] [5] [6] . It was demonstrated, that CD34+/CD133+-stem cells in septic patients contain a distinct amount of additional KDR (vascular endothelial growth factor receptor 2) expression-as indicative of endothelial progenitor cells (EPC) - [7] and are increasingly mobilized in sepsis compared to non-septic ICU patients and healthy individuals [8] . Furthermore the increased mobilization of CD34 + /CD133 + -stem cells in sepsis correlated with survival [8] . The recruitment of vascular progenitor cells to inflammatory endothelial tissue is a complex process and involves a coordinated multi-step-process including mobilization, chemotaxis, homing and paracrine interaction with the resident cells [9] . Homing of endothelial progenitors, for example, to the target tissue has been shown to be influenced by various chemokines, cytokines, adhesion molecules and proteases [10] [11] [12] [13] . Certain adhesion molecules, which play a critical role in leucocyte homing, were also identified as key regulators of transendothelial migration of EPC [14] . In that respect, E-selectin and P-selectin have been demonstrated as mediators of leucocyte rolling which are induced on EPC by the stromal cell factor 1 (SDF-1) and promote EPC homing to sites of critical ischemia [15] . Furthermore, Vascular Cell Adhesion Molecule-1 (VCAM-1) is needed for EPC adhesion to fibroblasts from arthritic tissue [16] . Nevertheless, the exact molecular mechanisms of vascular progenitor cell homing especially to sites of vascular inflammation in septic patients are still poorly understood.
Assuming, that homing of vascular progenitor cells in sepsis involves various mediators that recruit them to activated endothelium in response to a damage-induced inflammation, we set out to determine in septic patients which adhesion molecules are expressed by CD34 
Material and methods

Subjects
For this study, we enrolled over a 3-year period 30 septic patients from the Intensive Care Unit (ICU) of the University Medical Center Mannheim at admission to the ICU or within 48 hours after onset of sepsis. Selected patients met the diagnostic criteria for sepsis of the American College of Chest Physicians/Society of Critical Care Medicine [19] . The severity of sepsis was determined by the Simplified Acute Physiology Score (SAPS II) [20] , and mortality was specified by death occurring within 28 days after diagnosis. According to our previous publication [8], we used the following exclusion criteria: cardiogenic or hemorrhagic shock, chronic obstructive pulmonary disease, isolated acute respiratory distress syndrome, absence of mechanical ventilation, and use of statins, angiotensin-converting enzyme inhibitors, activated protein C, and hydrocortisone. We recruited 10 patients from the ICU who required mechanical ventilation and healthy volunteers from our laboratory staff as control groups. ICU controls did not meet the criteria for sepsis, septic shock, or systemic inflammatory response syndrome. 15 healthy subjects served as controls. The Ethics Committee of the University of Heidelberg has approved this study and written informed consent was obtained from all study subjects. 
Blood sampling
Blood (20 mL) from septic patients was obtained within 24hrs after onset of sepsis and from ICU controls within 24hrs after admission to the ICU. 
Flow cytometry
Enzyme-linked immunosorbent assay
The serum concentrations of Vascular Endothelial Growth Factor (VEGF) and Angiopoietin-2 (Ang2) were measured using enzyme-linked immunosorbent assay kits (R&D Systems, Wiesbaden-Nordenstadt, Germany) in triplicate samples according to the manufacturer's instructions.
Statistical analysis
For our statistical analyses we used both parametric and nonparametric methods. All presented data are displayed as mean ± SEM. We examined all data for normal and nonGaussian distribution by the Kolmogorov-Smirnov test. For comparison among normally distributed groups, one-way ANOVA, followed by pairwise multiple comparison (StudentNewman-Keuls method) was used. For non-normally distributed data, the nonparametric Kruskal-Wallis test followed by an all pairwise multiple comparison (Dunnett's method) was used. Since the mean age in the group of healthy controls was significantly lower than in the two patient groups, we adjusted for age to avoid confounders. For comparative analysis of survival in the group of septic patients , we used Student's t-test and U test. Logistic regression analysis was performed to predict survival probability from CD34 + /CD133 + -stem cell numbers and from adhesion molecule expression by CD34 + /CD133 + -stem cells.
All assessed variables have been put under correlation analyses (Pearson/Spearman). P<0.05 was considered statistically significant. We used the SAS system (version 8.2) for all the above mentioned aspects. The logistic regression curve has been generated with Minitab 18 (Friedrichsdorf, Germany).
Results
Patient population
The relevant clinical data of study participants regarding age, gender, mortality, SAPSII score, type of infection, White Blood Cell (WBC) count and procalcitonin (PCT) are summarized in Table 1 . (Fig 2) . Similar results were found for Intercellular Adhesion Molecule-1 (ICAM-1) and E-selectin. However, differences in the expression of L-selectin between septic patients and ICU patients or healthy controls were less prominent (14% increase of CD34 + /CD133 + -stem cell counts in septic patients compared to ICU patients) (Fig 2) . Logistic regression analysis revealed an inverse association between expression of VCAM-1 and survival probability in the sepsis group (p = 0.05). For the other adhesion molecules, no such significant difference could be found (Fig 2) . In addition, there Table 1 . Clinical characteristics of patients and controls. Clinical data of study participants for age, gender, mortality, Simplified Acute Physiology Score (SAPS) II score, type of infection, white blood cell (WBC) count and procalcitonin (PCT) refer to the time point of blood sampling. The mean age in the group of healthy controls was significantly lower compared to the patient groups (p = 0,0001). There was no statistical difference in mean age between the two patient groups (p = 0,065). was no significant association between patient age and VCAM-1 expression by CD34 + / CD133 + -stem cells (Fig 3) . 
Group
Serum concentrations of VEGF and Ang-2 are elevated in septic patients
Serum VEGF and Ang2 concentrations were significantly higher in septic patients compared with ICU and healthy controls (Fig 3) . Within the group of septic patients, the serum concentration of VEGF and Ang-2 between survivors and non-survivors was not significantly different (Fig 4) .
For the entire study population, a significant correlation between CD34 + /CD133 + -stem cell numbers and serum levels of VEGF (r = 0.31, p = 0.03) and Ang-2 (r = 0.32, p = 0.02) was observed, indicating that high numbers of CD34 + /CD133 + -stem cells are correlated to high serum levels of VEGF and Ang-2. The CD34 + /CD133 + -stem cell numbers in septic patients or in the survivor/non-survivor subgroups was not correlated with serum levels of VEGF or Ang-2. exp(1,56 -0,0366 VCAM-1 expression) ). p(100), probability of survival, VCAM-1, vascular adhesion molecule-1. The recruitment of vascular stem cells to sites of endothelial injury and dysfunction is mediated by several adhesion molecules, which are essential for binding of those cells to the endothelial layer or to the extracellular matrix [10-12,21]. Endothelial progenitor cells, for example, express PSGL-1 (P-selectin-glycprotein-ligand) and are recruited to activated endothelial cells via P-and E-selectin [11, 22] . In a murine endotoxemia model, VCAM-1 was shown to be [28, 29] . We could in our previous studies already demonstrate that septic patients exhibit increased levels of circulating endothelial progenitor cells themselves, using FACS analysis [8] . Other groups have confirmed these results in human studies using the flow cytometry to analyze and count endothelial progenitors [30] [31] [32] ; besides human studies, Luo et al. showed an increase of circulating vascular stem cells in the early phase of endotoxemia induced sepsis in pigs with a peak after 72 hours [33] . However, studies based on the isolation of vascular progenitor cells by colony forming assays instead of flow cytometry did not show a significant increase in progenitor cell mobilization in sepsis [34, 35] . The differences in methodology might explain the differences in demonstrated vascular stem cell number changes in sepsis. In our current study the detected an increase in CD34 + / CD133 + -stem cell numbers in septic patients using flow cytometry indicates, that there seems to be a distinct positive impact of sepsis on CD34 + /CD133 + -stem cell mobilization, which might reflect the need for vascular repair.
Mobilizing vascular stem cells from the bone marrow during inflammatory diseases is a multi-faceted process, not only regulated by surface bound adhesion molecules, but also by a variety of paracrine factors and downstream signaling cascades [36] . It has been demonstrated, that the mobilization and general function of vascular stem cells like migration and proliferation are improved by circulating growth factors such as VEGF and Ang2 [37] [38] [39] [40] . With regards to sepsis, a correlation between increased plasma VEGF levels and severity of Multi-Organ-Dysfunction-Syndrome (MODS) has been reported by several groups [41, 42] . Based on those studies, VEGF was discussed to influence sepsis-associated capillary leakage [41] and be an important determinant of sepsis morbidity and mortality [43] . However, a recent study by Besnier et al. could show, that anti-VEGF therapy in septic mice did not influence survival [44] . Ang2 serum levels are also increased in septic patients, which is associated with a poor prognosis, as Ang2 is destabilizer of mature endothelial linings and a promoter of vascular leakage [45] . In this study, we confirmed the increase of VEGF serum levels in septic patients, but did not observe significant serum level differences between survivors and nonsurvivors similar to our previous work [8] . Comparable results were found for Ang-2. The clinical impact of the combined increase in VEGF and Ang2-serum levels on vascular stem cell functions like homing and trans-endothelial migration in septic patients remains to be determined in future studies. However, we could demonstrate a correlation between CD34 [30, 31, 33] . Contrary to that, the research group of Kung et al. recently saw a negative association between sepsis survival and endothelial progenitor cell numbers [32] . In the light of this controversy, our current data revealed slightly higher CD34 + / CD133 + -stem cell counts in sepsis-surviving patients, however, this difference was not significant. Yet, CD34 + /CD133 + -stem cell levels in sepsis-survivors older than 54 years were significantly increased over sepsis-non-survivors. We saw in our study, that CD34 + /CD133 + -stem cell levels in general were lower in patients with an age below 55 years compared to older patients, which we suspected to be a probable confounding factor in the survival analysis. Therefore, the impact of patient age on sepsis survival associated with vascular stem cells should be selectively assessed in future studies.
In general, the limitation of studies investigating vascular stem cells is the lack of consensus on an unique phenotypic identification of the "endothelial progenitor cell" due to the absence of a unique marker. As mentioned before, cell culturing methods based on colony forming assays or flow cytometry both have their advantages and disadvantages. According to the findings of Herrmann et al. we could demonstrate in our previous work, that bone marrow derived progenitors, with a high expression of CD34 and CD133 are rich in vascular progenitor cells, especially in sepsis [8] . Besides the hematopoetic stem cell marker CD34, we used the progenitor cell marker CD133 to exclude mature endothelial cells from FACS counting. Yet, since the classical definition of EPC requires also an endothelial marker protein like VEGF-R2 (KDR) or CD31, the stem cell populations used in our study include hematopoietic stem cells in their numbers. Another limitation of this study is its cross-sectional design and the subsequent lack of information on CD34 
